Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Orthopaedics
Published in: International Orthopaedics 6/2009

01-12-2009 | Original Paper

Risk factors for pulmonary embolism after hip and knee arthroplasty: a population-based study

Authors: Stavros G. Memtsoudis, Melanie C. Besculides, Licia Gaber, Spencer Liu, Alejandro González Della Valle

Published in: International Orthopaedics | Issue 6/2009

Login to get access

Abstract

Pulmonary embolism (PE) is a cause of death after total hip and knee arthroplasty (THA, TKA). We characterised the patient population suffering from in-hospital PE and identified perioperative risk factors associated with PE using nationally representative data. Data from the National Hospital Discharge Survey between 1990 and 2004 on patients who underwent primary or revision THA/TKA in the United States were analysed. Multivariate regression analysis was performed to determine if perioperative factors were associated with increased risk of in-hospital PE. An estimated 6,901,324 procedures were identified. The incidence of in-hospital PE was 0.36%. Factors associated with an increased risk for the diagnosis of PE included: revision THA, female gender, dementia, obesity, renal and cerebrovascular disease. An increased association with PE was found among patients with diagnosis of Adult Respiratory Distress Syndrome (ARDS), psychosis (confusion), and peripheral thrombotic events. Our findings may be useful in stratifying the individual patient’s risk of PE after surgery.
Appendix
Available only for authorised users
Literature
1.
Barba R, Zapatero A, Losa JE, Valdes V, Todoli JA, Di Micco P, Monreal M (2008) Body mass index and mortality in patients with acute venous thromboembolism: findings from the RIETE registry. J Thromb Haemost 6:595–600CrossRefPubMed
2.
Beksac B, Gonzalez Della Valle A, Anderson J, Sharrock NE, Sculco TP, Salvati EA (2007) Symptomatic thromboembolism after one-stage bilateral THA with a multimodal prophylaxis protocol. Clin Orthop Relat Res 463:114–119PubMed
3.
Beksac B, Gonzalez Della Valle A, Salvati EA (2006) Thromboembolic disease after total hip arthroplasty: who is at risk? Clin Orthop Relat Res 453:211–224CrossRefPubMed
4.
Bhattacharyya T, Iorio R, Healy WL (2002) Rate of and risk factors for acute inpatient mortality after orthopaedic surgery. J Bone Joint Surg Am 84-A:562–572PubMed
5.
Burnett RS, Clohisy JC, Wright RW, McDonald DJ, Shively RA, Givens SA, Barrack RL (2007) Failure of the American College of Chest Physicians-1A protocol for lovenox in clinical outcomes for thromboembolic prophylaxis. J Arthroplasty 22:317–324CrossRefPubMed
6.
Butt AJ, McCarthy T, Kelly IP, Glynn T, McCoy G (2005) Sciatic nerve palsy secondary to postoperative haematoma in primary total hip replacement. J Bone Joint Surg Br 87-B:1465–1467CrossRef
7.
Gangireddy C, Rectenwald JR, Upchurch GR, Wakefield TW, Khuri S, Henderson WG, Henke PK (2007) Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg 45:335–341CrossRefPubMed
8.
Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG (2004) Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:338S–400SCrossRefPubMed
9.
Iezzoni LI, Foley SM, Daley J, Hughes J, Fisher ES, Heeren T (1992) Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA 267:2197–2203CrossRefPubMed
10.
Keenan CR, White RH (2007) The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med 13:377–383PubMed
11.
Keene J, Hope T, Fairburn CG, Jacoby R (2001) Death and dementia. Int J Geriatr Psychiatry 16:969–974CrossRefPubMed
12.
Lowe GD, Haverkate F, Thompson SG, Turner RM, Bertina RM, Turpie AG, Mannucci PM (1999) Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: the ECAT DVT study. European Concerted Action on Thrombosis. Thromb Haemost 81:879–886PubMed
13.
Mahomed NN, Barrett J, Katz JN, Baron JA, Wright J, Losina E (2005) Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am 87:1222–1228CrossRefPubMed
14.
Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL (2003) Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology 99:552–560CrossRefPubMed
15.
Memtsoudis SG, Gonzalez Della Valle A, Besculides MC, Garber LK, Laskin RS (2008) Trends in demographics, comorbidity profiles, in-hospital complications and mortality associated with primary knee arthroplasty. 3,830,420 hospital discharges in the Unites States between 1990 and 2004. J Arthroplasty (in press)
16.
Memtsoudis SG, Gonzalez Della Valle A, Besculides MC, Garber LK, Sculco TP (2008) In-hospital complications and mortality of patients undergoing primary unilateral, bilateral and revision total knee arthroplasty. A study of 4,169,489 hospital discharges in the United States between 1990 and 2004. Clin Orthop (in press)
17.
Monreal M, Falga C, Valle R, Barba R, Bosco J, Beato JL, Maestre A (2006) Venous thromboembolism in patients with renal insufficiency: findings from the RIETE Registry. Am J Med 119:1073–1079CrossRefPubMed
18.
Mont MA, Jones LC, Rajadhyaksha AD, Shuler MS, Hungerford DS, Sieve-Smith L, Wang P, Cordista AG, Glueck CJ (2004) Risk factors for pulmonary emboli after total hip or knee arthroplasty. Clin Orthop 422:154–163CrossRefPubMed
19.
Parvizi J, Sullivan TA, Trousdale RT, Lewallen DG (2001) Thirty-day mortality after total knee arthroplasty. J Bone Joint Surg Am 83-A:1157–1161PubMed
20.
Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE (2007) Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am 89:33–38CrossRefPubMed
21.
22.
Ridker RM, Miletich JP, Hennekens CH, Buring JE (1997) Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 277:1305–1307CrossRefPubMed
23.
Sanchez-Ballester J, Smith M, Hassan K, Kershaw S, Elsworth CS, Jacobs L (2005) Wound infection in the management of hip fractures: a comparison between low-molecular weight heparin and mechanical prophylaxis. Acta Orthop Belg 71:55–59PubMed
24.
25.
Sharrock NE, Gonzalez Della Valle A, Go G, Lyman S, Salvati EA (2008) Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res 466:714–721CrossRefPubMed
26.
Sharrock NE, Gonzalez Della Valle A, Go G, Lyman S, Salvati EA (2008) Reply to letter to editor: potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res 466(8)
27.
Stein PD, Beemath A, Meyers FA, Olson RE (2007) Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease. J Cardiovasc Med (Hagerstown) 8:253–257
28.
Warwick D, Dahl OE, Fisher WD (2008) Orthopaedic thromboprophylaxis: limitations of current guidelines. J Bone Joint Surg Br 90:127–132CrossRefPubMed
29.
White RH, Dager WE, Zhou H, Murin S (2006) Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost 96:267–273PubMed
30.
White RH, Gettner S, Newman JM, Trauner KB, Romano PS (2000) Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med 343:1758–1764CrossRefPubMed
31.
White RH, Henderson MC (2002) Risk factors for venous thromboembolism after total hip and knee replacement surgery. Curr Opin Pulm Med 8:365–371CrossRefPubMed
32.
White RH, Zhou H, Romano PS (1998) Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 128:737–740PubMed
33.
Zhan C, Kaczmarek R, Loyo-Berrios N, Sangl J, Bright RA (2007) Incidence and short-term outcomes of primary and revision hip replacement in the United States. J Bone Joint Surg Am 89:526–533CrossRefPubMed
Metadata
Title
Risk factors for pulmonary embolism after hip and knee arthroplasty: a population-based study
Authors
Stavros G. Memtsoudis
Melanie C. Besculides
Licia Gaber
Spencer Liu
Alejandro González Della Valle
Publication date
01-12-2009
Publisher
Springer-Verlag
Published in
International Orthopaedics / Issue 6/2009
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-008-0659-z

Other articles of this Issue 6/2009

International Orthopaedics 6/2009 Go to the issue

Original Paper

Influence of the sagittal balance of the spine on the anterior pelvic plane and on the acetabular orientation

Original Paper

Blood loss in computer-assisted mobile bearing total knee arthroplasty. A comparison of computer-assisted surgery with a conventional technique

Original Paper

Reinfusion of unwashed salvaged blood after total knee arthroplasty in patients with rheumatoid arthritis

Original Paper

Five-year DEXA study of 88 hips with cemented femoral stem

Original Paper

Surgical correction of Madelung’s deformity by combined corrective radioulnar osteotomy: 14 cases with four-year minimum follow-up

Original Paper

Measurement of knee joint motion using digital imaging